S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:CLSN

Celsion News Headlines

$1.71
-0.14 (-7.57 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.41
Now: $1.71
$1.80
50-Day Range
$0.87
MA: $1.76
$2.81
52-Week Range
$0.43
Now: $1.71
$6.50
Volume8.80 million shs
Average Volume26.16 million shs
Market Capitalization$63.98 million
P/E RatioN/A
Dividend YieldN/A
Beta2.42

Headlines

Celsion (NASDAQ CLSN) News Headlines Today

Source:
SourceHeadline
Celsion (NASDAQ:CLSN) Rating Lowered to Sell at Zacks Investment ResearchCelsion (NASDAQ:CLSN) Rating Lowered to Sell at Zacks Investment Research
marketbeat.com - February 15 at 7:33 PM
Do Options Traders Know Something About Celsion (CLSN) Stock We Dont? - Yahoo FinanceDo Options Traders Know Something About Celsion (CLSN) Stock We Don't? - Yahoo Finance
finance.yahoo.com - March 5 at 12:39 PM
Do Options Traders Know Something About Celsion (CLSN) Stock We Dont?Do Options Traders Know Something About Celsion (CLSN) Stock We Don't?
finance.yahoo.com - March 5 at 12:39 PM
NeoPhotonics to Host Call to Discuss Optical Communications Trends and Technologies on March 10, 2021NeoPhotonics to Host Call to Discuss Optical Communications Trends and Technologies on March 10, 2021
finance.yahoo.com - March 5 at 12:39 PM
Celsion (NASDAQ:CLSN) Trading Down 9.3%Celsion (NASDAQ:CLSN) Trading Down 9.3%
americanbankingnews.com - March 4 at 8:44 PM
Celsion (NASDAQ:CLSN) Stock Price Crosses Above Two Hundred Day Moving Average of $0.96Celsion (NASDAQ:CLSN) Stock Price Crosses Above Two Hundred Day Moving Average of $0.96
americanbankingnews.com - March 4 at 12:20 AM
Poster on Celsion Corporations Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Womens Cancer - GlobeNewswirePoster on Celsion Corporation's Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women's Cancer - GlobeNewswire
globenewswire.com - March 2 at 12:23 PM
Celsion: Still Waiting For Godot - Seeking AlphaCelsion: Still Waiting For Godot - Seeking Alpha
seekingalpha.com - March 1 at 8:31 PM
Celsion Corporation to Participate in the Virtual 33ʳ ? Annual Roth ConferenceCelsion Corporation to Participate in the Virtual 33ʳ ? Annual Roth Conference
marketwatch.com - February 28 at 1:37 PM
Celsion Corporation to Participate in the Virtual 33ʳᵈ Annual Roth Conference - GlobeNewswireCelsion Corporation to Participate in the Virtual 33ʳᵈ Annual Roth Conference - GlobeNewswire
globenewswire.com - February 26 at 3:47 PM
Celsion Corporation to Participate in the Virtual 33ʳᵈ Annual Roth Conference - Yahoo FinanceCelsion Corporation to Participate in the Virtual 33ʳᵈ Annual Roth Conference - Yahoo Finance
finance.yahoo.com - February 26 at 9:58 AM
Is Celsion Stock a Buy Right Now? This Is What You Need to Know - Yahoo FinanceIs Celsion Stock a Buy Right Now? This Is What You Need to Know - Yahoo Finance
finance.yahoo.com - February 26 at 12:00 AM
NeoPhotonics 400G ZR Modules Support Extended Operation up to 80C Case TemperaturesNeoPhotonics 400G ZR Modules Support Extended Operation up to 80C Case Temperatures
finance.yahoo.com - February 25 at 6:59 PM
Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores - GlobeNewswireCelsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores - GlobeNewswire
globenewswire.com - February 25 at 1:58 PM
Celsion (NASDAQ:CLSN) Trading Down 5%Celsion (NASDAQ:CLSN) Trading Down 5%
americanbankingnews.com - February 24 at 10:38 PM
Celsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program - Yahoo FinanceCelsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program - Yahoo Finance
finance.yahoo.com - February 24 at 3:05 PM
CLSN Stock: Why Biotech Celsion Is Soaring Today - NasdaqCLSN Stock: Why Biotech Celsion Is Soaring Today - Nasdaq
nasdaq.com - February 24 at 10:04 AM
Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - GlobeNewswireCelsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - GlobeNewswire
globenewswire.com - February 23 at 1:28 PM
Celsion (NASDAQ:CLSN) Shares Gap Down to $2.81Celsion (NASDAQ:CLSN) Shares Gap Down to $2.81
americanbankingnews.com - February 23 at 11:31 AM
Celsion (CLSN) Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - StreetInsider.comCelsion (CLSN) Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - StreetInsider.com
streetinsider.com - February 23 at 8:27 AM
CLSN Stock: Why Biotech Celsion Is Soaring Today - InvestorPlaceCLSN Stock: Why Biotech Celsion Is Soaring Today - InvestorPlace
investorplace.com - February 23 at 8:27 AM
Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug - TheStreetCelsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug - TheStreet
thestreet.com - February 23 at 8:27 AM
Celsion receives Fast Track designation for cancer immunotherapy - Seeking AlphaCelsion receives Fast Track designation for cancer immunotherapy - Seeking Alpha
seekingalpha.com - February 23 at 8:27 AM
Celsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program - GlobeNewswireCelsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program - GlobeNewswire
globenewswire.com - February 23 at 8:27 AM
Celsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) ProgramCelsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program
finance.yahoo.com - February 23 at 8:27 AM
Celsion (NASDAQ:CLSN) Stock Price Up 47.9%Celsion (NASDAQ:CLSN) Stock Price Up 47.9%
americanbankingnews.com - February 22 at 7:01 PM
Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - Yahoo FinanceCelsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - Yahoo Finance
finance.yahoo.com - February 22 at 2:47 PM
Celsion (NASDAQ:CLSN) Trading Down 7.3%Celsion (NASDAQ:CLSN) Trading Down 7.3%
americanbankingnews.com - February 16 at 10:32 PM
Celsion Co. (NASDAQ:CLSN) Short Interest UpdateCelsion Co. (NASDAQ:CLSN) Short Interest Update
americanbankingnews.com - February 14 at 4:12 PM
Celsion (CLSN) Announces Formation of Vaccine Advisory Board - StreetInsider.comCelsion (CLSN) Announces Formation of Vaccine Advisory Board - StreetInsider.com
streetinsider.com - February 12 at 5:54 PM
Celsion is extending gains; forms a vaccine advisory board - Seeking AlphaCelsion is extending gains; forms a vaccine advisory board - Seeking Alpha
seekingalpha.com - February 12 at 5:54 PM
Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech? - PRNewswireThinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech? - PRNewswire
prnewswire.com - February 12 at 12:54 PM
Celsion Corporation Announces Formation of Vaccine Advisory Board - Yahoo FinanceCelsion Corporation Announces Formation of Vaccine Advisory Board - Yahoo Finance
finance.yahoo.com - February 12 at 12:54 PM
CLSN Stock: Why Biotech Company Celsion Is Soaring Today - InvestorPlaceCLSN Stock: Why Biotech Company Celsion Is Soaring Today - InvestorPlace
investorplace.com - February 11 at 8:02 PM
Celsion shares jump on pipeline and business update - Seeking AlphaCelsion shares jump on pipeline and business update - Seeking Alpha
seekingalpha.com - February 11 at 8:02 PM
Celsion (NASDAQ:CLSN) Trading 17.4% Higher Celsion (NASDAQ:CLSN) Trading 17.4% Higher
americanbankingnews.com - February 11 at 7:34 PM
Celsion Corporation Issues Letter to Stockholders - Yahoo FinanceCelsion Corporation Issues Letter to Stockholders - Yahoo Finance
finance.yahoo.com - February 11 at 3:01 PM
Investors Purchase Large Volume of Call Options on Celsion (NASDAQ:CLSN)Investors Purchase Large Volume of Call Options on Celsion (NASDAQ:CLSN)
americanbankingnews.com - February 11 at 11:54 AM
Thinking about buying stock in Seelos Therapeutics, Celsion Corp, Zosano Pharma, Outlook Therapeutics, or Infinity Pharmaceuticals? - PRNewswireThinking about buying stock in Seelos Therapeutics, Celsion Corp, Zosano Pharma, Outlook Therapeutics, or Infinity Pharmaceuticals? - PRNewswire
prnewswire.com - February 11 at 10:01 AM
Celsion (CLSN) Files Provisional US Patent Application for a Broad Range of Next Generation DNA Vaccines - StreetInsider.comCelsion (CLSN) Files Provisional US Patent Application for a Broad Range of Next Generation DNA Vaccines - StreetInsider.com
streetinsider.com - January 28 at 3:11 PM
Celsion Corporation Files Provisional U.S. Patent Application For A Broad Range Of Next Generation DNA Vaccines - BenzingaCelsion Corporation Files Provisional U.S. Patent Application For 'A Broad Range Of Next Generation DNA Vaccines' - Benzinga
benzinga.com - January 28 at 3:11 PM
Celsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA VaccinesCelsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA Vaccines
finance.yahoo.com - January 28 at 3:11 PM
Celsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA Vaccines - GlobeNewswireCelsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA Vaccines - GlobeNewswire
globenewswire.com - January 28 at 10:08 AM
Celsion down 15% on closing $35M direct offering, priced at-the-market - Seeking AlphaCelsion down 15% on closing $35M direct offering, priced at-the-market - Seeking Alpha
seekingalpha.com - January 27 at 1:10 PM
CELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES - Yahoo FinanceCELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES - Yahoo Finance
finance.yahoo.com - January 26 at 10:54 PM
CELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES - GlobeNewswireCELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES - GlobeNewswire
globenewswire.com - January 26 at 5:52 PM
CELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULESCELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES
finance.yahoo.com - January 26 at 5:52 PM
CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES - StreetInsider.comCELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES - StreetInsider.com
streetinsider.com - January 24 at 12:15 AM
Looking Into Celsions Return On Capital Employed - Yahoo FinanceLooking Into Celsion's Return On Capital Employed - Yahoo Finance
finance.yahoo.com - January 23 at 2:15 PM
Celsion (CLSN) announces $35 million registered direct offering of common stock - StreetInsider.comCelsion (CLSN) announces $35 million registered direct offering of common stock - StreetInsider.com
streetinsider.com - January 22 at 5:48 PM
Celsion shares down 9% after announcing capital raise - Seeking AlphaCelsion shares down 9% after announcing capital raise - Seeking Alpha
seekingalpha.com - January 22 at 5:48 PM
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.